Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In a paper published in Nature Neuroscience, the Fugger Group describe molecular pathways of MS neurodegeneration in unprecedented detail.

© Colin Behrens/Pixabay

Progressive multiple sclerosis (MS) is a common autoimmune disease characterised by neurodegeneration of the central nervous system. Despite progress in characterising the disease, MS is currently without effective treatments to tackle disease progression.

A new paper published in Nature Neuroscience provides a detailed picture of the molecular pathways altered in MS, tracking more than 4000 gene/protein pairings across stages of MS disease progression using spatial transcriptomics and proteomics.

Speaking to Nature Reviews Neurology, Professor Lars Fugger, leader of the Oxford Centre for Neuroinflammation at the MRC Human Immunology Unit  and lead author of the study said ‘'Spatial transcriptomics is a novel technique that can detect the expression of thousands of genes with spatial resolution directly in the tissue. Thus, it becomes possible to combine the structural detail of microscopy with high-dimensional measurements to capture complex disease pathways.'

By locating expression in the tissue and simultaneously measuring that gene expression, researchers were able to identify signals that could contribute to disease progression, and those that could represent potential therapeutic targets. By identifying protein and RNA expression changes in disease and highlighting those found in tissues affected in MS, the researchers created a prioritisation list for future drug targets.

Read the full paper online at Nature Neuroscience.

Similar stories

MRC HIU research at the 2022 Grand Challenges Annual Meeting

Nicole Stoffel and Michael Zimmerman presented at the 18th Grand Challenges Annual Meeting which took place in Brussels, Belgium on 23rd- 26th October 2022.

2022 RDM Graduate Prize Winners

This year's RDM winners are Edward Jenkins, Antje Rottner, and Akshay Shah.

New UK research consortium formed to tackle monkeypox outbreak

Investigation of the T cell responses against monkeypox virus will be led by Prof. Tao Dong at the CAMS-Oxford Institute and MRC Human Immunology Unit.

Ziqi Long receives NDM Prize

DPhil student Ziqi Long has been commended in the category NDM Overall Prize at the annual Nuffield Department of Medicine (NDM) Awards

Beyond Boundaries at the Oxford Imaging Symposium

Held on 29th September 2022, the symposium brought together researchers from across the world to present the latest applications of advanced imaging.

Anjali Kusumbe receives the RMS Life Sciences Medal

The Royal Microscopical Society awards celebrate the best in microscopy, recognising those making a special contribution to microscopy, cytometry and imaging.